TORONTO--(BUSINESS WIRE)--Highland Therapeutics Inc.’s wholly owned subsidiary, Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), today announced positive clinical data from the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results